Yasemin Başbınar

933 total citations
47 papers, 367 citations indexed

About

Yasemin Başbınar is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yasemin Başbınar has authored 47 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Yasemin Başbınar's work include Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Diet and metabolism studies (3 papers). Yasemin Başbınar is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Diet and metabolism studies (3 papers). Yasemin Başbınar collaborates with scholars based in Türkiye, United States and Switzerland. Yasemin Başbınar's co-authors include Hülya Ellıdokuz, Gizem Calibasi‐Kocal, Nazli Mert-Ozupek, Gamze Çapa Kaya, Emine Acar, Ömer Yılmaz, Ender Ellidokuz, Chia‐Wei Cheng, Omid Mashinchian and İlhan Öztop and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yasemin Başbınar

44 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasemin Başbınar Türkiye 11 133 82 51 50 49 47 367
Haneen A. Basheer Jordan 13 146 1.1× 100 1.2× 44 0.9× 44 0.9× 34 0.7× 28 426
Muhammad Arshad Pakistan 8 201 1.5× 90 1.1× 51 1.0× 42 0.8× 39 0.8× 36 507
Yue Shang China 13 292 2.2× 91 1.1× 25 0.5× 55 1.1× 24 0.5× 39 487
Katharina R. Beck Switzerland 15 185 1.4× 41 0.5× 22 0.4× 48 1.0× 45 0.9× 22 539
Niloufar Mohammadkhani Iran 9 190 1.4× 100 1.2× 25 0.5× 66 1.3× 29 0.6× 11 467
Jacob Cardenas United States 10 201 1.5× 76 0.9× 18 0.4× 79 1.6× 26 0.5× 15 468
Ali Anissian Iran 11 151 1.1× 51 0.6× 28 0.5× 47 0.9× 20 0.4× 21 365
João Crispim Encarnação Portugal 10 196 1.5× 100 1.2× 20 0.4× 38 0.8× 40 0.8× 12 394
Kimberly L. Moulton United States 4 303 2.3× 90 1.1× 40 0.8× 98 2.0× 43 0.9× 6 527
Minfeng Ye China 11 161 1.2× 89 1.1× 24 0.5× 62 1.2× 42 0.9× 17 395

Countries citing papers authored by Yasemin Başbınar

Since Specialization
Citations

This map shows the geographic impact of Yasemin Başbınar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasemin Başbınar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasemin Başbınar more than expected).

Fields of papers citing papers by Yasemin Başbınar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasemin Başbınar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasemin Başbınar. The network helps show where Yasemin Başbınar may publish in the future.

Co-authorship network of co-authors of Yasemin Başbınar

This figure shows the co-authorship network connecting the top 25 collaborators of Yasemin Başbınar. A scholar is included among the top collaborators of Yasemin Başbınar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasemin Başbınar. Yasemin Başbınar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göksel, Tuncay, Su Özgür, Aslı Teti̇k Vardarli, et al.. (2024). Prognostic and predictive role of liquid biopsy in lung cancer patients. Frontiers in Oncology. 13. 1275525–1275525. 2 indexed citations
2.
Calibasi‐Kocal, Gizem, et al.. (2024). Effect of Collagen-Coating Variations on the Morphology and Viability of Human Vascular Smooth Muscle Cells. Journal of Basic and Clinical Health Sciences. 8(3). 726–733. 1 indexed citations
3.
Calibasi‐Kocal, Gizem, et al.. (2024). AI-Assisted Survival Prediction in Colorectal Cancer: A Clinical Decision Support Tool. Journal of Basic and Clinical Health Sciences. 8(3). 771–778.
4.
Canda, Aras Emre, et al.. (2024). In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens. SHILAP Revista de lepidopterología. 9(1). 23–29. 1 indexed citations
5.
Calibasi‐Kocal, Gizem, et al.. (2024). Combined inhibition of the FAK-Rho-ROCK signaling cascade, one of the important players in mechanotransduction, in colorectal cancers. Journal of Basic and Clinical Health Sciences. 8(3). 765–770. 1 indexed citations
6.
7.
Başbınar, Yasemin, et al.. (2023). High and low dietary fiber consumption and cancer risk: a comprehensive umbrella review with meta-meta-analysis involving meta-analyses of observational epidemiological studies. Critical Reviews in Food Science and Nutrition. 65(9). 1617–1630. 6 indexed citations
8.
Öztop, İlhan, Yasemin Başbınar, Tarkan Ünek, et al.. (2023). The Prognostic Significance of Circulating Tumor Cells in Patients with Pancreatobiliary Cancer. The Turkish Journal of Gastroenterology. 34(3). 278–286. 1 indexed citations
9.
Başbınar, Yasemin, et al.. (2023). The Role of Cyanidin-3-O-glucoside in Modulating Oxaliplatin Resistance by Reversing Mesenchymal Phenotype in Colorectal Cancer. Nutrients. 15(22). 4705–4705. 4 indexed citations
12.
Calibasi‐Kocal, Gizem, et al.. (2022). Acousto-holographic reconstruction of whole-cell stiffness maps. Nature Communications. 13(1). 7351–7351. 10 indexed citations
13.
Mert-Ozupek, Nazli, Gizem Calibasi‐Kocal, Nur Olgun, et al.. (2022). In-silico molecular interactions among the secondary metabolites of Caulerpa spp. and colorectal cancer targets. Frontiers in Chemistry. 10. 1046313–1046313. 5 indexed citations
14.
Işık, Zerrin, et al.. (2022). In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps. PLoS ONE. 17(4). e0267973–e0267973. 2 indexed citations
15.
Calibasi‐Kocal, Gizem, et al.. (2021). Drug Resistance Mechanisms on Colorectal Cancer. Journal of Basic and Clinical Health Sciences. 5(1). 88–93. 4 indexed citations
16.
Mert-Ozupek, Nazli, et al.. (2021). Semi-Purified Saponins of Holothuria poli Associated Antiproliferation in Tumor Cell Lines. Nutrition and Cancer. 74(4). 1511–1518. 1 indexed citations
17.
Mert-Ozupek, Nazli, et al.. (2021). Soluble and Insoluble Dietary Fiber Consumption and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis. Nutrition and Cancer. 74(7). 2412–2425. 44 indexed citations
18.
Calibasi‐Kocal, Gizem, et al.. (2021). A Promising, Novel Radiosensitizer Nanodrug Complex for Oral Cavity Cancer: Cetuximab and Cisplatin-Conjugated Gold Nanoparticles. Balkan Medical Journal. 38(5). 278–286. 16 indexed citations
19.
Vardarli, Aslı Teti̇k, Levent Pelit, Ayça Aykut, et al.. (2020). * Concordance in molecular genetic analysis of tumour tissue, plasma, and exhaled breath condensate samples from lung cancer patients. Journal of Breath Research. 14(3). 36001–36001. 9 indexed citations
20.
Başbınar, Yasemin, et al.. (2019). Role of mesenchymal stem cell-derived soluble factors and folic acid in wound healing. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(3). 914–921. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026